| |
| |
|
| Insider
Information: |
Stonehouse Jon P |
| Relationship: |
Director |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,331,856 |
|
|
Indirect Shares
|
40,000 |
|
|
| Direct
Value |
$7,278,094 |
|
|
|
Indirect Value
|
$257,600 |
|
|
| Total
Shares |
1,371,856 |
|
|
| Total
Value |
$7,535,694 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
President & CEO, Direc... |
2024-05-13 |
1,127,770 |
2024-05-13 |
40,000 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
204,086 |
2018-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-12-03 |
4 |
OE |
$1.20 |
$96,000 |
D/D |
80,000 |
807,674 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2013-01-31 |
4 |
A |
$1.38 |
$4,140 |
D/D |
3,000 |
340,225 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-05-17 |
4 |
OE |
$1.42 |
$100,006 |
D/D |
70,427 |
725,519 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-01 |
4 |
OE |
$1.42 |
$305,182 |
D/D |
214,917 |
1,116,747 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-02 |
4 |
OE |
$1.42 |
$117,372 |
D/D |
82,656 |
984,486 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2019-11-18 |
4 |
B |
$1.45 |
$72,500 |
D/D |
50,000 |
778,086 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-12-01 |
4 |
B |
$1.48 |
$81,450 |
D/D |
55,000 |
155,603 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2009-01-30 |
4 |
B |
$1.62 |
$4,845 |
D/D |
3,000 |
103,603 |
2.73 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-11-03 |
4 |
B |
$1.74 |
$43,729 |
D/D |
25,000 |
100,603 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$5,881 |
D/D |
(2,761) |
664,585 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2011-08-08 |
4 |
B |
$2.52 |
$25,190 |
D/D |
10,000 |
217,492 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-08-04 |
4 |
B |
$2.82 |
$677 |
D/D |
240 |
65,603 |
2.73 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-08-11 |
4 |
B |
$2.95 |
$22,736 |
D/D |
7,700 |
73,303 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-08-12 |
4 |
B |
$3.10 |
$7,124 |
D/D |
2,300 |
75,603 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-03-21 |
4 |
OE |
$3.22 |
$99,997 |
D/D |
31,055 |
1,039,794 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2014-05-09 |
4 |
OE |
$3.26 |
$232,635 |
D/D |
40,417 |
645,633 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-02-28 |
4 |
OE |
$3.26 |
$185,654 |
D/D |
56,949 |
698,316 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2011-03-18 |
4 |
AB |
$3.40 |
$33,988 |
D/D |
10,000 |
194,180 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2008-01-31 |
4 |
B |
$3.50 |
$10,506 |
D/D |
3,000 |
65,363 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-20 |
4 |
OE |
$4.15 |
$99,998 |
D/D |
24,096 |
676,326 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2020-12-15 |
4 |
OE |
$4.15 |
$557,254 |
D/D |
134,278 |
918,364 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2018-11-09 |
4 |
B |
$4.56 |
$45,600 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-01-11 |
4 |
OE |
$4.73 |
$870,320 |
D/D |
184,000 |
1,085,602 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2012-03-02 |
4 |
S |
$4.78 |
$13,006 |
D/D |
(2,721) |
239,384 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$13,336 |
D/D |
(2,716) |
647,951 |
0 |
- |
|
80 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
